In Fig. 8a, the strongest predictors were NAFLD/NASH and degree of fibrosis, followed by the other senescence-associated hepatic markers, p21 and p16. Regression also revealed that these predictors were statistically significant. Here, CDKN1A is linked to metabolic dysfunction-associated steatohepatitis.